Skip to content

Comparison Of Pracchana Karma And Shudha Langalimool Kalka Lepa With Platelet Rich Plasma Therapy In The Treatment Of Alopecia(Indralupta)

To Study The Effect Of Pracchana Karma (Micro-Needling) And Shudha Langalimool Kalka Lepa In Comparison To Platelet Rich Plasma Therapy In The Management Of Indralupta (Alopecia).

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052506
Enrollment
45
Registered
2023-05-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L63- Alopecia areata Health Condition 2: L64- Androgenic alopecia

Interventions

None listed

Sponsors

RGGPG Ayurvedic College,Paprola
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient showing signs and symptoms of the disease Indralupta /Alopecia. 2.Patients willing and able to participate in the trial. 3.Patients between 18-60 years of age irrespective of gender, religion and occupation will be selected for the study.

Exclusion criteria

Exclusion criteria: 1.Patient below 18 and above 60 years. 2.Patient who are suffering from any serious conditions like cardiac disease, hypertension, diabetes, malignancy or infectious diseases such as T.B. 3.Low platelet count or any platelet dysfunction. 4.Patient taking anti-coagulants and anti-platelets. 5.Patients with chronic skin diseases. 6.Patients showing positive KOH will be excluded. 7.Pregnant and lactating females.

Design outcomes

Primary

MeasureTime frame
Overall improvement which will be shown by the patients in the signs and symptoms of the disease.Timepoint: 3months

Secondary

MeasureTime frame
Growth of hair in the bald patch.Timepoint: 63days

Countries

India

Contacts

Public ContactDr Garima Bhardwaj

Rajiv Gandhi Government P.G. Ayurvedic College and Hospital, Paprola

drrajeshsood@gmail.com9418102424

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026